Tombacz et al., 2015 - Google Patents
Magnetic iron oxide nanoparticles: Recent trends in design and synthesis of magnetoresponsive nanosystemsTombacz et al., 2015
View PDF- Document ID
- 1057660564221118561
- Author
- Tombacz E
- Turcu R
- Socoliuc V
- Vekas L
- Publication year
- Publication venue
- Biochemical and biophysical research communications
External Links
Snippet
Recent developments in nanotechnology and application of magnetic nanoparticles, in particular in magnetic iron oxide nanosystems, offer exciting possibilities for nanomedicine. Facile and precise synthesis procedures, high magnetic response, tunable morphologies …
- 230000005291 magnetic 0 title abstract description 161
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tombacz et al. | Magnetic iron oxide nanoparticles: Recent trends in design and synthesis of magnetoresponsive nanosystems | |
| Morales et al. | Contrast agents for MRI based on iron oxide nanoparticles prepared by laser pyrolysis | |
| Martinez-Boubeta et al. | Learning from nature to improve the heat generation of iron-oxide nanoparticles for magnetic hyperthermia applications | |
| Kafrouni et al. | Recent progress on magnetic nanoparticles for magnetic hyperthermia | |
| Kashevsky et al. | Study of cobalt ferrite nanosuspensions for low-frequency ferromagnetic hyperthermia | |
| Hong et al. | Preparation, characterization and application of bilayer surfactant-stabilized ferrofluids | |
| Horst et al. | Hybrid nanomaterials based on gum Arabic and magnetite for hyperthermia treatments | |
| Majeed et al. | Enhanced specific absorption rate in silanol functionalized Fe3O4 core–shell nanoparticles: Study of Fe leaching in Fe3O4 and hyperthermia in L929 and HeLa cells | |
| Coral et al. | Effect of nanoclustering and dipolar interactions in heat generation for magnetic hyperthermia | |
| González-Fernández et al. | Magnetic nanoparticles for power absorption: Optimizing size, shape and magnetic properties | |
| Easo et al. | Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies | |
| Dennis et al. | Nearly complete regression of tumors via collective behavior of magnetic nanoparticles inhyperthermia | |
| Ahmadi et al. | Synthesis of Fe3O4 nanocrystals using hydrothermal approach | |
| Rana et al. | On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: functionalization, conjugation and drug release kinetics | |
| Mazario et al. | Magnetic hyperthermia properties of electrosynthesized cobalt ferrite nanoparticles | |
| Qiao et al. | Magnetorheological behavior of Pickering emulsions stabilized by surface-modified Fe3O4 nanoparticles | |
| Salas et al. | Relationship between physico-chemical properties of magnetic fluids and their heating capacity | |
| Shi et al. | Enhanced specific loss power from Resovist® achieved by aligning magnetic easy axes of nanoparticles for hyperthermia | |
| Mishra et al. | Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging | |
| Marín et al. | Development of magnetite nanoparticles/gelatin composite films for triggering drug release by an external magnetic field | |
| Bakuzis et al. | Chain formation and aging process in biocompatible polydisperse ferrofluids: Experimental investigation and Monte Carlo simulations | |
| Nandwana et al. | Exchange coupling in soft magnetic nanostructures and its direct effect on their theranostic properties | |
| Coral et al. | Nanoclusters of crystallographically aligned nanoparticles for magnetic thermotherapy: aqueous ferrofluid, agarose phantoms and ex vivo melanoma tumour assessment | |
| Chen et al. | Simulating physiological conditions to evaluate nanoparticles for magnetic fluid hyperthermia (MFH) therapy applications | |
| Haracz et al. | Effect of surfactant for magnetic properties of iron oxide nanoparticles |